ECHOing Excellence: MASLD/MASH Made Manageable in Primary Care - CME - Guideline Central

CME

Title
ECHOing Excellence: MASLD/MASH Made Manageable in Primary Care
Link
Description
This 90-minute video activity is comprised of four recorded lectures from a live ECHO® meeting series entitled “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) ECHO® ECHOing Excellence: MASLD/MASH Made Manageable in Primary Care” that took place January through February of 2026. Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined as the presence of hepatic steatosis in addition to one or more cardiometabolic risk factors and the absence of other identifiable causes. MASLD is the most common chronic liver condition globally, impacting over one-third of adults. It affects more than 65% of those with obesity or type 2 diabetes (T2D), conditions commonly seen in primary care and endocrinology clinics. The curriculum was produced for a primary care audience and features four expert speakers discussing how to better diagnose and risk stratify people with or at risk for developing MASLD/MASH, how to use non-invasive tests (NITs), and how to implement strategies to improve management of patients with MASLD.
Target Audience
This online activity is designed for a primary care audience. It is open to physicians, nurse practitioners (NPs), physician associates (PAs), and nurses who care for people with MASLD/MASH.
Learning Objectives
  • Define the conditions of MASLD and MASH and their relationship to cardiometabolic conditions such as obesity and type 2 diabetes.
  • Integrate available non-invasive tests into clinical practice for the identification, risk-stratification, and monitoring of patients with MASLD/MASH.
  • Identify emerging treatments for MASLD/MASH and the criteria for patient eligibility.
  • Outline evidence-based management strategies for individuals with MASLD/MASH, including how available therapies (e.g., GLP-1 RAs) can target multiple disease mechanisms.
Estimated Duration
90 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Primary Care
Keywords
metabolic dysfunction-associated steatotic liver disease (MASLD)
Disclosures and Disclaimers
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Accredited Providers
  • Boston University Chobanian & Avedisian School of Medicine’s Center for Continuing Education
Commercial Support
  • Novo Nordisk
Activity Expiration Date
March 30, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1.5 CreditsACCME- Accreditation Council for Continuing Medical Education
AAPA Category 1 Credit1.5 CreditsAAPA- American Academy of Physician Associates
Nursing1.5 Contact HoursANCC - American Nurses Credentialing Center
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.